Skip to content

cfHPV DNA assay


cfHPV DNA represents a promising surrogate of disease burden in patients with HPV-driven cancers. Applying ultra-sensitive technology to detect and quantify circulating HPV-DNA using HPV-SEQ is an innovative and exciting step forward in the development of more targeted approaches when managing HPV-associated cancers. HPV-SEQ has high analytical and clinical sensitivity, with the ability to reliably and consistently detect as low as 2 copies of HPV 16 and HPV 18 DNA.

cfHPV DNA panel Clinically relevant gene regions Intended uses
HPV-SEQ & HPV-related cancers HPV 16, HPV 18
  • Therapy selection
  • Therapeutic monitoring
  • Recurrence surveillance
  • Test specifications
    Cell-free DNA analysis for solid tumors
    Sample types
    • Whole blood
    • Frozen plasma
    • Purified cfDNA
    • 2x10 mL blood collection tubes required, additional tube may be recommended for certain studies
    • Sysmex Inostics' specimen collection and shipping kits include Streck blood collection tubes
    • Plasma or purified cfDNA from samples collected in Streck or EDTA tubes is acceptable
    7 – 10 Business days